SCHEMBL6092115

SCHEMBL6092115

Nc1[c]sc(C(=O)NCc2ccccc2Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
NPC1 O15118 2/20 0.51
RAB9A P51151 1/20 0.51
KMT2A Q03164 2/20 0.51
TP53 P04637 2/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 3/20 0.48
TSHR P16473 2/20 0.48
PKM P14618 1/20 0.48
POLB P06746 2/20 0.48
MAPT P10636 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
GAA P10253 1/20 0.47
CYP2C19 P33261 1/20 0.47
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6093165 0.82 EPHX2 (0.51) CNR1CNR2
SCHEMBL6097363 0.81 PLAU (0.48) HDAC1HDAC6KMT2ATP53SMN1; SMN2
SCHEMBL23474255 0.75 TP53 (0.54) HDAC1HDAC6NPC1RAB9AKMT2A
SCHEMBL23511435 0.74 HDAC1 (0.56) HDAC1HDAC6NPC1RAB9AKMT2A
SCHEMBL23511678 0.73 HDAC1 (0.51) HDAC1HDAC6NPC1RAB9AKMT2A
SCHEMBL14727425 0.72 ALDH1A1 (0.68) NPC1RAB9AKMT2ATP53SMN1; SMN2
SCHEMBL29994178 0.72 ALDH1A1 (0.68) NPC1RAB9AKMT2ATP53SMN1; SMN2
SCHEMBL10321815 0.71 SMN1; SMN2 (0.63) NPC1RAB9AKMT2ATP53SMN1; SMN2
SCHEMBL6093295 0.71 MAPT (0.47) KMT2ATP53SMN1; SMN2ALDH1A1POLB
SCHEMBL5846817 0.71 SMN1; SMN2 (0.56) NPC1RAB9AKMT2ATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7015223-B1 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2006-03-21 US claimed
US-20040116430-A1 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-06-17 US claimed
US-6653316-B1 Coronary artery and cerebrovascular diseases PHARMACIA CORPORATION 2003-11-25 US claimed
WO-2001087851-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIMIDINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO claimed
WO-2001087842-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO claimed
US-7015223-B1 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2006-03-21 US disclosed
US-6870056-B1 Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2005-03-22 US disclosed
US-20040116430-A1 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-06-17 US disclosed
US-6653316-B1 Coronary artery and cerebrovascular diseases PHARMACIA CORPORATION 2003-11-25 US disclosed
WO-2001087851-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIMIDINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO disclosed
WO-2001087842-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO disclosed